Drugs and Devices

FDA approves new drug treatments for type 2 diabetes

On Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares